盐酸帕洛诺司琼、格拉司琼、昂丹司琼预防化疗呕吐的比较
黄雄
摘要(Abstract)：
目的:观察三种止吐药预防化疗引起呕吐的临床疗效和不良反应。方法:采用DDP化疗方案治疗的肿瘤患者60例随机分为3组,分别给予国产帕洛诺司琼、格拉司琼、昂丹司琼,观察3种药物预防呕吐的效果。结果:急性期防治呕吐的有效率帕洛诺司琼组为75%,格拉司琼组为65%,昂丹司琼组为55%;延迟期分别为70%,55%和50%,3种止吐药毒副反应均为便秘、腹泻及头痛,但程度较轻。结论:帕洛诺司琼、格拉司琼、昂丹司琼是DDP化疗方案患者的有效止吐药,帕洛诺司琼疗效最强,3种药物不良反应轻,病人可耐受。
关键词(KeyWords)：
呕吐;抗肿瘤联合化疗方案;止吐药;治疗结果
基金项目(Foundation):
作者(Author):
黄雄
DOI: 10.19367/j.cnki.1000-2707.2010.03.028
参考文献(References)：
- [1]Piraccini G,Stolz R,Tei M,et al.Pharmacokinetic features of a novel5-HT3-receptor antagonist:palonosetron(RS25259-197)[J].Proc Am Soc Clin Oncol2001(20):400a(Abstr1595).
- [2]Macciocchi A,Gallagher S.A phase II dose-ranging study to assess single intravenous doses of palonosetron for the prevention of highly emetogenic chemotherapy-induced nausea and vomiting[J].Proc Am Soc Clin Oncol,2002(21):471a(Abstr1480).
- [3]Gmlh R,Lichinitser M,Vegt SV,et al.Palonosetron im-proves prevention o f chemotherapy induced nausea and vomiting following moderately emetoge-nic chemotherapy:results of a double-blind randomized phaseⅢtrial compa-ring single doses of palono-setron with ondansetron[J].Ann of Oncol,2003(10):1570-l577.
- [4]Johnston D,Latreille J,Laberge F,et al.Preventing nause-a and vomiting during days2-7following high dose cispla-tin chemotherapy(HDCP).A study by the National Can cer Institute of Canada Clinical Trials Group(NCICCTG)[J].Proc AmSoc Clin Oncol,1995(14):529(Abstr1745).
- [5]Kaizer L,Warr D,Hoskins P,et al.Effet of schedule and maintenance on the antiemetic efficacy of ondansetroncombined with dexamethasone in acute and delayed nause-a and emesis in patients receiving moderately emetogenic chemotherapy:a phase III trial by the National Cancer In-stitute of Canada Clinical Trials Group[J].J Clin Oncol1994(12):1050-1057.
- [6]Aapro MS,Thuerlimann B,Sessa C,et al.A randomized,double-blind trial to compare the clinical efficacy of gran-isetron with metoclopramide,both combined with dexam-ethasone in the prophylaxis of chemotherapy-induced de-layed emesis[J].Ann Oncol,2003(14):291-297.
- [7]Eisenberg P,Figueroa-Vadillo J,Zamora R,et a1.Im-proved prevention of moderately emetogenic chemothera-py-induced nausea and vomiting with palonose tron,a pharmacologically novel5-HT3receptor antagonist:re-sults of a phase III,single-dose trial versus dolasetren[J].Cancer,2003(11):2473-2482.
文章评论(Comment)：
|
||||||||||||||||||
|
||||||||||||||||||